Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plasmogel is a biotechnology company specializing in the development of advanced regenerative medicine solutions using a proprietary thermo-responsive hydrogel platform. Spun out from the University of Southern California, the company's technology utilizes autologous blood plasma to create a biodegradable scaffold for tissue engineering and drug delivery. Their primary focus includes bone regeneration, wound healing, and dental applications, providing a biocompatible environment for cell growth and therapeutic agent release. The platform is designed to be injectable at room temperature and solidify at body temperature, offering a minimally invasive approach to complex tissue repair. By leveraging the patient's own biological materials, Plasmogel aims to reduce immunogenicity and enhance the integration of regenerative therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plasmogel.